An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)

PHASE3CompletedINTERVENTIONAL
Enrollment

560

Participants

Timeline

Start Date

March 1, 2016

Primary Completion Date

January 17, 2019

Study Completion Date

March 4, 2022

Conditions
Brain Cancer
Interventions
DRUG

Nivolumab

DRUG

Temozolomide

RADIATION

Radiotherapy

Trial Locations (125)

1011

Local Institution - 0057, Lausanne

1090

Local Institution - 0060, Vienna

Universitair Ziekenhuis Brussel, Brussels

1200

Cliniques Universitaires Saint-Luc, Brussels

1211

Local Institution - 0059, Geneva

2065

Royal North Shore Hospital, St Leonards

2100

Local Institution, Copenhagen

2170

Local Institution - 0002, New South Wales

3000

Uz Leuven, Leuven

3084

Local Institution - 0003, Heidelberg

3181

Local Institution - 0004, Prahran

4020

Local Institution - 0061, Linz

5000

Local Institution, Odense

6009

Local Institution - 0001, Nedlands

8091

Local Institution - 0053, Zurich

10032

Columbia University Medical Center (Cumc), New York

10065

Memorial Sloan Kettering Cancer Center, New York

10126

Local Institution - 0077, Torino

13005

Local Institution - 0024, Marseille

15706

Local Institution, Santiago de Compostela

18103

Local Institution - 0132, Allentown

19107

Local Institution - 0007, Philadelphia

20007

Georgetown University Medical Center, Washington D.C.

20089

Local Institution - 0135, Rozzano (milano)

20133

Local Institution - 0079, Milan

20246

Local Institution - 0054, Hamburg

21287

Johns Hopkins University School Of Medicine, Baltimore

27710

Preston Robert Tisch Brain Tumor Center at Duke University, Durham

28007

Local Institution - 0029, Madrid

28041

Local Institution, Madrid

28204

Levine Cancer Institute, Charlotte

29425

Medical University Of South Carolina, Charleston

30322

Emory University - Winship Cancer Institute, Atlanta

31100

Local Institution - 0106, Toulouse

33136

University Of Miami Sylvester Comprehensive Cancer Center, Miami

33612

Moffitt Cancer Center, Tampa

35000

Centre Eugene Marquis, Rennes

35128

Local Institution - 0126, Padua

37232

Vanderbilt University Medical Center, Nashville

37404

Local Institution - 0090, Chattanooga

40139

Local Institution - 0076, Bologna

40202

Norton Cancer Institute, Louisville

43210

Local Institution - 0095, Columbus

44195

Local Institution - 0010, Cleveland

46014

Local Institution - 0025, Valencia

48149

Local Institution - 0050, Münster

48202

Local Institution - 0006, Detroit

49100

Local Institution - 0096, Petah Tikva

50937

Local Institution - 0139, Cologne

53100

Local Institution - 0078, Siena

53105

Local Institution - 0051, Bonn

54035

Local Institution - 0101, Nancy

59037

Local Institution, Lille

60528

Local Institution - 0049, Frankfurt am Main

60637

The University Of Chicago, Chicago

63110

Washington University School OF Medicine-Siteman Cancer Center, St Louis

64239

Local Institution - 0097, Tel Aviv

66205

University Of Kansas Medical Center, Westwood

69120

Local Institution - 0052, Heidelberg

69677

Local Institution - 0032, Bron

72076

Local Institution - 0056, Tübingen

75010

Local Institution - 0023, Paris

75651

Local Institution - 0038, Paris

77030

University Of Texas Md Anderson Cancer Ctr, Houston

79106

Local Institution - 0073, Freiburg im Breisgau

80952

Local Institution - 0080, Gdansk

81675

Local Institution - 0138, Munich

84112

Local Institution - 0068, Salt Lake City

85013

Local Institution - 0083, Phoenix

90048

Cedars Sinai Medical Center, Los Angeles

91054

Local Institution - 0072, Erlangen

92123

Sharp Memorial Hospital, San Diego

93053

Local Institution - 0055, Regensburg

95816

Sutter Institute For Medical Research, Sacramento

98122

Swedish Neuroscience Institute, Seattle

105229

Local Institution - 0070, Moscow

115478

Local Institution - 0105, Moscow

1040045

Local Institution - 0114, Chuo-ku

1138655

Local Institution - 0128, Bunkyo-ku

1628666

Local Institution - 0112, Tokyo

2520375

Local Institution - 0133, Sagamihara-shi

2608677

Local Institution - 0125, Chiba

3058576

Local Institution - 0111, Tsukuba

4668560

Local Institution - 0115, Nagoya

5731191

Local Institution, Hirakata-shi

6128555

Local Institution - 0116, Kyoto

6500017

Local Institution - 0129, Kobe

7008558

Local Institution - 0134, Okayama

7348551

Local Institution - 0123, Hiroshima

8608556

Local Institution - 0119, Kumamoto

8908520

Local Institution - 0131, Kagoshima

9200934

Local Institution - 0121, Kanazawa

9909585

Local Institution - 0110, Yamagata

35294-3410

University of Alabama at Birmingham, Birmingham

90095-1769

Local Institution - 0019, Los Angeles

94143-0372

The Regents of the University of California, San Francisco, San Francisco

06520

Yale Cancer Center, New Haven

02215

Dana-Farber Cancer Institute, Boston

Massachusetts General Hospital, Boston

08820

JFK Medical Center, Edison

07601

Local Institution - 0064, Hackensack

75390-8852

University Of Texas Southwestern Medical Center, Dallas

V5Z 4E6

BC Cancer - Vancouver, Vancouver

M5G 2M9

Princess Margaret Cancer Centre, Toronto

H3A 2B4

Montreal Neurological Institute and Hospital, Montreal

0608648

Local Institution - 0122, Sapporo

606-8507

Local Institution - 0117, Kyoto

565-0871

Local Institution - 0130, Suita-shi

350-1298

Local Institution - 0113, Hidaka

181-8611

Local Institution - 0118, Mitaka-shi

1066 CX

NKI AVL, Amsterdam

9713 AP

Universitair Medisch Centrum Groningen, Groningen

3015 CE

Erasmus Mc, Rotterdam

3584CX

Local Institution - 0063, Utrecht

0379

Local Institution, Oslo

02-781

Local Institution - 0081, Warsaw

08916

Local Institution, Badalona-Barcelona

08035

Local Institution, Barcelona

08036

Local Institution - 0028, Barcelona

221 85

Local Institution, Lund

171 64

Local Institution, Solna

NW1 2PG

University College Hospital, London

M20 4BX

Christie Hospital Nhs Found. Trust, Manchester

SM2 5PT

Royal Marsden Hospital, Sutton

G12 0YN

Beaston West of Scotland Cancer Centre, Glasgow

Sponsors
All Listed Sponsors
collaborator

Ono Pharmaceutical Co. Ltd

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY

NCT02617589 - An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer) | Biotech Hunter | Biotech Hunter